You are here: Industry Insights > NHS

News List

NHS aims for one link worker per primary care network from July pharmatimes
April 02, 2019
From July 1 the NHS will put its social prescription plan into action, aiming for one link worker per primary care network and 100% reimbursement.
NICE backs PredictImmune's IBD prognosis test pharmatimes
April 02, 2019
PredictImmune has announced that the National Institute for Health and Care Excellence (NICE) has published a Medtech Innovation Briefing (MIB) on the use of its PredictSURE IBD technology, for the prognosis of inflammatory bowel disease.
NICE recommendation for Steglatro in type II diabetes pharmatimes
March 28, 2019
The National Institute of Care and Health Excellence (NICE) has recommended MSD’s Steglatro (ertugliflozin) for use within the NHS, for the treatment of adults with type II diabetes.
Many NHS partnerships with drug companies out of public sight: BMJ investigation expressbpd
March 28, 2019
Drug companies spent over £7.5m on joint working in 2016-17, but 1 in 5 NHS trusts are keeping details secret. This goes against official guidance that urges openness and transparency
SMC says ‘no’ to Novartis’ Kymriah for adults with lymphoma pharmatimes
March 12, 2019
Adults with lymphoma will not be able to access Novartis’ CAR-T therapy Kymriah on the NHS in Scotland after cost-regulators rejected funding for the treatment in this setting.
86% of Britain believe NHS faces a ‘major’ funding problem pharmatimes
March 08, 2019
The 2018 British Social Attitudes (BSA) survey has been released, investigating how Britain will navigate the global, social and economic challenges of the near future, covering pressing topics such as Brexit and NHS funding.
Telehealth could save NHS England £7.5bn pharmaphorum
March 07, 2019
Adopting digital health tools such as telehealth services across the region could save NHS England £7.5 billion, according to a new white paper.
Experts warn all forms of Brexit would harm NHS pharmaceutical-technology
February 28, 2019
Brexit in all forms will cause harm to the UK National Health Service (NHS), however, a no-deal scenario will result in the worst outcomes, according to a new review published in The Lancet....
Outcome-based payment system could expedite cancer treatment pharmaceutical-technology
February 26, 2019
Commissioned in alliance with the Greater Manchester Health and Social Care Partnership, the report suggests that payment for cancer drugs should be adjusted based on how well they work in practice.....
NICE refuses to endorse Biomarin’s Batten disease drug pharmaceutical-technology
February 26, 2019
The UK National Institute for Health and Care Excellence (NICE) has published a draft guidance saying that Biomarin’s therapy for Batten disease, Brineura (cerliponase alfa), cannot be recommended for use in the National Health Service (NHS)....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page